Zobrazeno 1 - 10
of 20
pro vyhledávání: '"SUSHMA KADIYALA"'
Publikováno v:
Acta Médica Peruana, Vol 40, Iss 2 (2023)
Externí odkaz:
https://doaj.org/article/2d809b855a2e4d0ea63937ebffa906c4
Autor:
Sherin Elsa Mathews MD, Jessica Castellanos-Diaz MD, Ashok Srihari MD, Sushma Kadiyala MD, Julio Leey-Casella MD, Hans K. Ghayee DO, Amie Ogunsakin MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 9 (2021)
A 67-year-old male was admitted with shortness of breath and diarrhea. His COVID-19 polymerase chain reaction test was positive, and he was found to be in acute heart failure. Troponin levels were elevated, echocardiogram showed ejection fraction of
Externí odkaz:
https://doaj.org/article/0419a366c3c441169eea7afb3019f161
Autor:
Sushma Kadiyala, MD, Yasmin Khan, MD, Valeria de Miguel, MD, Megan N. Frone, MS, CGC, Fiemu Nwariaku, MD, Jennifer Rabaglia, MD, Stacey Woodruff, MD, Elizabeth E. King, MD, Sumitha S. Hathiramani, MD, Karel Pacak, MD, PhD, Hans K. Ghayee, DO
Publikováno v:
AACE Clinical Case Reports, Vol 4, Iss 3, Pp 186-190 (2018)
ABSTRACT: Objective: Succinate dehydrogenase complex, subunit D (SDHD) gene mutations are most commonly associated with head and neck paragangliomas. We describe a pair of cases with early-onset, bilateral pheochromocytoma (PCC) and paraganglioma (PG
Externí odkaz:
https://doaj.org/article/4ac371901afa45da87f4511af3b8ed48
Publikováno v:
JCEM Case Reports. 1
Publikováno v:
The Journal of Clinical Endocrinology and Metabolism
ContextThe burden of cirrhosis from nonalcoholic fatty liver disease (NAFLD) is reaching epidemic proportions in the United States. This calls for greater awareness among endocrinologists, who often see but may miss the diagnosis in adults with obesi
Autor:
Kenneth Cusi, Amalia Gastaldelli, S. Sabatini, Stephen A. Harrison, Fernando Bril, Melania Gaggini, Diana Barb, Renata Belfort-DeAguiar, Fabrizia Carli, Sushma Kadiyala, Vincenzo Positano
Publikováno v:
Liver International
BACKGROUND AND AIMS Peroxisome proliferator-activated receptor (PPAR)-γ agonists decrease hepatic/visceral fat (VF) and improve necroinflammation despite subcutaneous (SC) fat weight-gain. Understanding the impact of changes in VF, VF-to-SC fat dist
Publikováno v:
Journal of the Endocrine Society. 6:A180-A181
Introduction Zoledronic acid, used for treatment of osteoporosis, Paget's disease of the bone, hypercalcemia of malignancy etc. is a bisphosphonate known for its anti-resorptive effect. A common adverse reaction with this medication is mild to modera
Autor:
CARLOS E. MENDEZ, ELIZABETH A. MATTOX, SUSHMA KADIYALA, MAJLINDA XHIKOLA, KONSTANTINA YANTSIDES, ANGELA D. OIEN, IRENE O'SHAUGHNESSY, ANN E. HANSEN, JESSICA LUCAS, KYLE HAZEN, LUZ M. SEMEAH, JULIO A. LEEY
Publikováno v:
Diabetes. 71
Access to specialized diabetes care is limited due to shortage of endocrinologists and distance to specialty clinics. In addition, referrals to out-of-network providers frequently results in suboptimal care coordination. Tele-mentoring models such as
Publikováno v:
Journal of the Endocrine Society. 6:A563-A563
Introduction/Background Galactorrhea in men is rare, with a reported prevalence of 5.5%. It tends to occur bilaterally rather than unilaterally. Among the etiologies of galactorrhea, pharmacologic agents, pituitary tumors, and hypothalamic and pituit
Publikováno v:
Journal of the Endocrine Society. 6:A161-A161
Introduction Denosumab is a receptor activator of nuclear factor kappa-B (RANK) ligand inhibitor used for treatment of osteoporosis and bone metastases in patients with solid tumors. Denosumab induced hypophosphatemia has been reported in less than 1